The family who drowned after the sinking of a refugee boat in the English Channel have been pictured – as a search for their missing 15-month-old baby continues.The bodies of Kurdish-Iranian Rasoul Iran-Nejad, 35, Shiva Mohammad Panahi, 35, Anita, nine, and Armin, six, have been found and identified, the BBC reports.Their 15-month-old son, Artin, is believed to be still missing. The family is believed to be from the city of Sardasht in western Iran, close to the border with Iraq.Rasoul’s brother told the channel he had sold all of his belongings and paid more than £20,000 to smugglers in a bid to secure a better future for his family.Pictures of the family have been shared publicly by a human rights organisation. تصاویری از اعضای خانوادە سردشتی کە در آبهای فرانسە غرق شدەاند https://t.co/KrHDJrFBLOpic.twitter.com/d4VN376ejb— Hengaw Human Rights Organization (@HengawO) October 28, 2020The tragedy is believed to be the single biggest loss of life during the current migrant crisis.More than a dozen people from the boat have been taken to hospitals in Calais and Dunkirk, according to the Maritime Prefecture of the Channel and the North Sea.Charities say there is “no excuse for failing to act now” and called on the UK Government to create a legal route for refugees. Refugees charity Care4Calais said it was “utterly devastated”.Bertrand Ringot, the mayor of Gravelines, south-west of Dunkirk, described the deaths as “tragic”.He added that as the end of the Brexit transition period approaches, he will call for more security resources in the area around the port.Bella Sankey, director of Detention Action, said: “News that a child has died at sea while trying to reach safety in the UK is the horror that we dreaded would come.“Where is the decency and common humanity of the UK government?“How can they allow our children to perish in this way? It would be easy to create a legal route for refugees who reach northern France to seek asylum in the UK; there is no excuse for failing to act now.”Home secretary Priti Patel was strongly criticised earlier this year for suggesting sending in the Navy to stop refugees crossing the Channel, despite the fact the UK’s resettlement scheme has been closed since March – meaning there is no safe, legal route for refugees to reach the UK by other means.Mariam Kemple Hardy, head of campaigns at Refugee Action, said the incident was “absolutely heartbreaking”.She added: “Our thoughts are with the people caught up in this horrible tragedy, their families, and the rescuers.“No one wants to see people make dangerous crossings but the government’s hostile rhetoric does nothing to help.“It must stop trying to look tough and urgently create more safe and legal routes for people to seek sanctuary in the UK.”Shadow home secretary Nick Thomas-Symonds tweeted: “This is an absolute tragedy. Our thoughts are with those who have lost loved ones and people who have been injured.“It is a heartbreaking reminder of the human cost of this crisis.”Yvette Cooper MP, chair of the Home Affairs Select Committee, said: “This is truly awful news – and it is even more distressing that children should be involved in this tragedy.“The thought of children ending up in the cold waves is terrible.“These boats are incredibly dangerous. The criminal gangs who organise journeys in these precarious dinghies are profiting from putting lives at risk and from other people’s desperation.“The Home Affairs Committee is currently conducting an inquiry into Channel crossings and into the work that is urgently needed to prevent more lives being lost.”Related... Two Young Children And Two Adults Die After Refugee Boat Sinks Off French Coast Opinion: Priti Patel Has Blood On Her Hands. Her Condolences Mean Nothing Exclusive: Child Refugee Resettlement Plummeted After Boris Johnson Became PM
7
UGC
The global Platelet Agitators market was valued at $XX million in 2019, and our analysts predict the global market size will reach $XX million by the end of 2027, growing at a CAGR of XX% between 2020 and 2027.Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances.The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.Download Free Sample Report @ https://www.eternityinsights.com/request-a-sample/30849This report analyses the impact of COVID-19 on this industry.COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.This report provides detailed historical analysis of global market for Platelet Agitators from 2014-2019, and provides extensive market forecasts from 2020-2027 by region/country and subsectors.It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Platelet Agitators market.Leading players of Platelet Agitators including:LABCOLDTERUMOSARSTEDTHelmer ScientificLMBEMSASKW Apparecchi ScientificiNuveBoekel ScientificNewmeditechMarket split by Type, can be divided into:Flatbed AgitatorCombination DevicesCircular AgitatorMarket split by Application, can be divided into:Autonomous Blood BanksHospital Based Blood BanksOtherMarket split by Sales Channel, can be divided into:Direct ChannelDistribution ChannelMarket segment by Region/Country including:North America (United States, Canada and Mexico)Europe (Germany, UK, France, Italy, Russia and Spain etc.)Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)South America (Brazil, Argentina and Colombia etc.
UGC
Market HighlightsCarcinoid tumor is a type of the neuroendocrine tumor.The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs.However, it can also be developed in pancreas, testicles, and ovaries.According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract.However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period.The serology segment is sub-segmented into blood test, urine test, molecular test, and others.
UGC
Market HighlightsAs per the latest report published by Market Research Future (MRFR) the Global In Vitro Diagnostics (IVD) Market will record a CAGR of 8.16% between 2018 and 2023.In-vitro diagnostics (IVD) combines the application of reagents, medical devices and accessories for performing complex test procedures on biological specimens such as tissue, blood and urine taken from human body.In-vitro diagnostics is increasingly used for diagnosis of medical conditions and detection of infection.Such factors are supporting the growth of the global IVD market.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1165IVD is more precise than conventional test procedures and thereby gaining a quick popularity.Demand for IVD services has grown substantially in recent years, which is attributable to the rising number of private diagnostics centers.Moreover, advances in diagnostics technology coupled with the expanding global geriatric population, which is necessitating faster and more accurate diagnosis is likely to provide an impetus to the in-vitro diagnostics market in the forthcoming years.
UGC
According to our latest market study on Paroxysmal Atrial Tachycardia Diagnosis Market Share – COVID-19 Impact and AnalysisThe “Paroxysmal Atrial Tachycardia Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.It Provides key statistics on the market status of the Paroxysmal Atrial Tachycardia Market players and is a valuable source of guidance and direction for companies and individuals interested in the industry.On conducting thorough research on the history as well as current growth parameters and growth prospects have been obtained with maximum particularity.Also read https://marketmirror24.com/2019/06/professional-insights-on-paroxysmal-atrial-tachycardia-market-comprehensive-latest-research-report-2019/The “Paroxysmal Atrial Tachycardia Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such As, Abbott Laboratories, Reliant Pharmaceuticals, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, GlaxoSmithKline plc, GE Healthcare, Glenmark Pharmaceuticals, Koninklijke Philips N.V., ANI Pharmaceuticals, Inc., Medtronic, Inc., Microport Scientific Corporation, St. Jude Medical, Inc., and Siemens AG and others.Paroxysmal Atrial Tachycardia Market Research Coverage:Changing market dynamics of the industryTo get a comprehensive overview of the Paroxysmal Atrial Tachycardia Market.Historical, current and projected market size in terms of volume and valueIn-depth market segmentationCompetitive landscapeThe report presents an all-inclusive database in a systematic and highly comprehensive manner.It intends to offer valid, factual, reliable, and easily understandable information about the Paroxysmal Atrial Tachycardia Market which makes it more eloquent.Our analysis team applies a tried and tested primary and secondary research methodology to provide accurate and indubitable findings.SegmentationThe global paroxysmal atrial tachycardia market has been segmented on the basis of types, condition, diagnosis, drugs, surgery and end user.Based on the types, the market has been segmented as AV nodal re-entrant tachycardia (AVNRT), AV reciprocating tachycardia (AVRT), and paroxysmal atrial tachycardia.Based on the diagnosis, the market has been segmented as electrocardiogram (ECG), echocardiogram, blood tests, and electrophysiology study (EPS) and others.Based on the treatment, the market has been segmented as calcium channel blockers, digoxin, beta-blockers, anti-arrhythmic medications, surgical ablation and others.Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.What are the Research Key Aspects of Paroxysmal Atrial Tachycardia Market:To Analyze the Consumption (Value & Volume), Product Type and Application, History Data From 2013 To 2017, And Forecast To 2023.To Understand the Structure of Paroxysmal Atrial Tachycardia Market by Identifying Its Various Subsegments.Focuses on The Key Manufacturers, To Define, Describe and Analyze the Sales Volume, Value, Market Share, Market Competition Landscape, SWOT Analysis and Development Plans in Next Few Years.To Analyze the Paroxysmal Atrial Tachycardia Market with Respect to Individual Growth Trends, Future Prospects, And Their Contribution to the Total Market.To Share Detailed Information About the Key Factors Influencing the Growth of The Market (Growth Potential, Opportunities, Drivers, Industry-Specific Challenges and Risks).To Analyze Competitive Developments Such as Expansions, Agreements, New Product Launches, And Acquisitions in The Paroxysmal Atrial Tachycardia Market.To Strategically Profile the Key Players and Comprehensively Analyze Their Growth Strategies.The report also appraises the supervisory scenarios which affect various decisions in the market.With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Paroxysmal Atrial Tachycardia Market.Openings for the future market growth were uncovered and preoccupied competitive threats also textured.Access complete Premium Research Report along with TOC, List of Figures and Tables at https://www.marketresearchfuture.com/reports/paroxysmal-atrial-tachycardia-market-4910About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
UGC
Market HighlightsThe global seasonal affective disorder market is growing moderately, and it is expected to grow at the same pace over the forecast period 2017-2018.Adoption of advanced diagnosis and treatment also plays an important role in the growth of this market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/4123The global market of seasonal affective disorder was around USD 521.0 million in 2016 and is expected to reach USD 694.9 million by 2023 at a projected CAGR of 4.2%.Major Players in Seasonal Affective Disorder MarketSome of the key market players: AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Henry Schein, Inc (US), Pfizer Inc. (US)Regional AnalysisThe global seasonal affective disorder market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & AfricaThe Americas dominate this market, particularly North America due to increasing prevalence of this disorder in the region.It is estimated that around 10 million Americans are affected by this disorder.Growing awareness in South American population regarding this disorder is major driving force.Increasing cases of seasonal affective disorder in Europe is leading the market growth.However, increasing healthcare expenditure, growing awareness, and increasing government support to improve life of patients drive this market.The Middle East & Africa region is expected to have the least growth during the forecast period due to lack of awareness about this disorder and limited access to healthcare facilities.SegmentationThe global seasonal affective disorder market is segmented on the basis of type, which includes fall and winter SAD, spring and summer SAD, and others.On the basis of diagnosis, the market is segmented into physical exam, lab tests, psychological evaluation, and others.Lab tests is sub-segmented into complete blood count (CBC), thyroid blood tests, and others.
Yesterday evening saw the single biggest loss of life in the English Channel in recent years – the death of two children – aged five and eight, along with two adults, after a migrant boat sank off the coast of northern France.Sadly, this story and the subsequent response from our government has become all too routine. Asylum-seekers desperately seeking safety in England are deprived of safe and legal routes to safety, are treated without humanity, and without any other plausible options on offer from the callous British government, are driven in desperation to such drastic measures. Related... Two Young Children And Two Adults Die After Refugee Boat Sinks Off French Coast Following the reports of these deaths, politicians offer up their sympathies. Indeed, both Priti Patel and Boris Johnson have expressed their condolences, making sure that both of their apologies refer to the “ruthless criminals” or “callous criminals” who they attribute to be at the helm of these tragic losses. In both cases, they abdicate culpability from a situation that the British government bears responsibility for. Their apologies have become as rehearsed as the faux compassion that they show. These words ring incredibly hollow given the government’s barbaric stance on asylum seekers and those seeking refugee. Words mean nothing without actions to back them up. Rather than pinning the blame on traffickers or migrants themselves, Patel should accept responsibility for the actions of her government, or rather lack thereof. Speaking to the Conservative Party conference earlier this year Patel said: “Those defending the broken [asylum] system – the traffickers, the do-gooders, the lefty lawyers, the Labour Party – they are defending the indefensible”. Is it indefensible to want a system that doesn’t force children to row in a boat across the Channel and die in the process? Related... Exclusive: Child Refugee Resettlement Plummeted After Boris Johnson Became PM Priti Patel Slams 'Do Gooders And Leftie Lawyers' Amid Criticism Of Asylum Plans Rather than implement punitive deterrents, the government should allow for safe legal access to prevent what are such preventable tragedies, at a time when the world does not need any more needless death. Last week, Lord Dubs, a former child refugee himself,  proposed for the fourth time an amendment to an immigration bill that would ensure that lone child refugees had the legal right to family reunion after the UK leaves the EU on 31 December. But, as the government, with a majority of 80, has thrown out the amendment three times before, it is likely they will do so again, leaving no safe alternates in its place.The one successful bid that Lord Dubs had previously secured – that the Home Office were obliged to accept at least 3,000 child refugees for resettlement – was compromised by ministers who placed a cap on the numbers. Last week, it was reported that those children – some as young as 12 – who have been able to make the journey across the Channel on small boats are being sent to adult detention centres where their safety and conditions are questionable.Time and time again this government has thwarted measures which offer basic humanity to some of the most vulnerable people which has lead to the death and endangerment of children. Rather than proposing draconian measures such as transferring asylum seekers to Papua New Guinea or Ascension Island, the government need to take responsibility for those who are attempting to travel to Britain with substantial measures rather than letting innocent children die. Related... Opinion: Marcus Rashford’s Campaign Isn’t An Inspiration – It’s A Tragedy In 2019, the Foreign Affairs Select Committee, which Patel was on, warned that “a policy that focuses exclusively on closing borders will drive migrants to take more dangerous routes, and push them into the hands of criminal groups”.   She was warned this would be the outcome, yet Patel only thinks of the cost of asylum. She told the Conservative Party conference that asylum seekers costs the UK £1bn a year – is that a humane way of thinking about the value of someone seeking safety’s life?Surely it is a waste of more time and money to order Parliamentary inquiries and reports if advice that does not fit the government agenda is so brazenly disregarded.Charities have said these deaths should serve as a “wake-up call” to those in power to realise that rigid borders and the current approach is not working for anyone.  We do not need more of the same – we need secure routes for those seeking asylum. The facts are that in the past decade more than 10,000 unaccompanied children have risked their lives to enter Britain, with more than 4,900 people entering the UK via small boats. We continue to hear of more cruel and tragic unnecessary deaths, and we repeatedly see the government voting against protections for child refugees.  The government needs to wake up and recognise that there is no safety in empty condolences – but there is reassurance in safe legal routes. Maighna Nanu is a freelance journalist. More in Opinion... Opinion: Paying For A Boots Covid Test Is Morally Indefensible Opinion: I'm An NHS Doctor. What I've Seen In The Second Wave Would Shock You Opinion: I’m Sick To Death Of Your Middle Class Stupidity About Food Poverty Opinion: Black History Doesn't Have To Be About Black Trauma
9
UGC
Avascular necrosis (AVN), or osteonecrosis or bone infarction, is the death of bone tissue attributed to interruption of the blood supply.At the onset, there may be no symptoms.But gradually joint pain may develop and may limit the ability to move.In sickle cell disorder, the risk factor of having AVN is very high due to the complications from restricted blood supply to vital organs in the body.However, it is very rare in sickle cell trait (SCT), a much milder form of sickle cell disease in which patients are usually asymptomatic.Treatment for AVN is recommended based on the stage of the disease coupled with the age of the patient.It also has a failure rate greater than 80-percent.Surgical treatment is recommended with a Stage II diagnosis, or very early in a Stage III diagnosis.
UGC
 Market Highlights The EMEA Blood Glucose Monitoring Devices Market is expected to grow at a CAGR of 6% during the forecast period 2017-2023.The blood glucose monitoring market is one of the rapidly growing markets across the globe owing to a huge growth in the incidence of diabetes.Additionally, factor such as increasing awareness and need of monitoring diseases help in boosting the market growth.However, high cost associated with monitoring and diagnosis of disease may restrain the market growth.According to the American Diabetes Association, the blood glucose levels for an adult without diabetes is below 100 mg/dl before meals and fasting, and is less than 140 mg/dl two hours after a meal.Request For Free Sample:https://www.marketresearchfuture.com/sample_request/607Regional AnalysisEurope, Middle East, and Africa (EMEA) blood glucose monitoring market are segmented into two important regions- Europe and the Middle East and Africa.Increasing the awareness among the people is adding fuel to the market growth.The Middle East and Africa hold the least share of the market owing to poor political conditions in Africa.The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries.
UGC
The INSULINOMA TREATMENT MARKET report, formulated recently by Market Research Future, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook.Insulinoma Market Information: By Types (Benign, Metastasize) By Diagnosis (Blood Test, Endoscopic Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Others), Treatment (Surgery, Drugs, Radiofrequency Ablation, Chemotherapy, Others) By End User – Global Forecast Till 2023Market OutlookInsulinomas are tumors formed on the pancreas which raise insulin levels and cause blood sugar levels to drop.Some of the genetic diseases which can cause these tumors include multiple endocrine neoplasia type 1, Von-Hippel Landau syndrome, and others.The global Insulinoma Treatment Market report compiled by Market Research Future (MRFR) consists of pertinent drivers, restraints, and opportunities for growth.The global Insulinoma Treatment Market size can touch USD 3.3 billion by 2023 while exhibiting a year-on-year growth rate of 3.3% during the forecast period (2017-2023).According to the research conducted by MRFR, close to 10% of patients with insulinomas are diagnosed with malignant and affect between 1-5 people out of a million.The rising use of dietary therapy combined with enteral feeds can keep malignant tumors at bay.Keeping this in mind, Lilly Diabetes, an arm of Eli Lilly and Company, has launched an Android version of the application which provide caregivers with information on injecting patients with the right dosage and alerts customers of the expiration date of kits.Segmentation:MRFR segments the global Insulinoma Treatment Market by type, diagnosis, treatment, and end-user.Based on the type, the Insulinoma Treatment Market can be segmented into benign and metastasize.Based on diagnosis, the Insulinoma Treatment Market includes magnetic resonance imaging (MRI), computed tomography (CT), endoscopic ultrasound, blood test, and others.Based on treatment, the Insulinoma Treatment Market comprises chemotherapy, surgery, radiofrequency ablation, and drugs.Based on end-user, the market targets academic & research, hospitals & clinics, and others.Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/4437Regional Analysis:The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are the four major regions in which the region-specific analysis of the global Insulinoma Treatment Market has been segmented.The Americas accounted for a majority of the global market and will be dominant during the forecast period.
Looking for the best PlayStation VR bundles including the headset, Move motion controllers and PS4 camera? You've come to the right place.
2
UGC
Tissue Engineering Market: Information by Material (Nano-fibrous Material, Biomimetic Material, Composite Material and Nano-composite Material) by Application (Orthopedics, Musculoskeletal and Spine, Skin/Integumentary, Cancer, Dental, Cardiology, Urology, Neurology, Cord Blood & Cell Banking and GI & Gynecology) and Region – Forecast till 2024Global Tissue Engineering Market is growing continually, witnessing a rising demand for the process.The market is predominantly driven by the rising popularity of the process in sectors ranging from musculoskeletal & spine, orthopedics, dental, and skin/integumentary to cancer, neurology, and cardiology treatments.Moreover, widening application areas of the tissue engineering process in stem cell reconstructive, skin grafting, and regenerative medicine to treat myriads of chronic diseases escalate the market growth to furthered height.According to Market Research Future (MRFR), the global tissue engineering market is poised to touch a valuation of USD 53,424.00 MN by 2024, growing steadily at 17.84% CAGR throughout the forecast period (2019 – 2024).Also, increasing prevalence of road accidents, injuries, and trauma cases drive the market substantially, driving the demand for transplants and surgical reconstruction procedures.Furthermore, the funding support for the ongoing tissue regeneration researches is a major growth driver supporting the market.Market drivers and restraints:Drivers:Increased focus of pharma & biotechnology companies on the development of tissue engineering-based therapies.Emergence of 3D bio-printing technology as a novel, cost effective tissue engineering strategy.Social media platforms and celebrity endorsements that are spreading the awareness of tissue engineering.Restraints:Lack of awareness of the benefits of tissue engineering.Lack of skilled professionals.Stringent regulatory policies.Global Tissue Engineering Market – SegmentsThe analysis has been segmented into three main dynamics to widen the scope of understanding,By Material : Nano-Fibrous & Biomimetic Materials, Composite & Nano-Composite Materials, and others.By Application : Musculoskeletal & Spine, Orthopedics, Cancer, Dental, Skin/Integumentary, Cardiology, Neurology, Urology, Cord Blood & Cell Banking, GI & Gynecology, and others.By Regions : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/2134Tissue Engineering Market – Regional AnalysisNorth America dominates the global tissue engineering market.Moreover, factors such as the rising prevalence of chronic diseases, the increasing clinical trials to evaluate the therapeutic potential of products, and well-spread awareness towards the therapeutic potency of therapy foster the regional market growth.
UGC
Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness.Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/atherectomy-devices-market-size/request-sample The key driving factors responsible for the growth of Atherectomy Devices market : Change in lifestyle trends and eating habits increase Consumption of cholesterol and fatty foods among individuals and lack of exercise which has been a major reason for coronary artery disease and high risk of heart attacks.It is estimated that 382 billion people throughout the world have diabetes.Added benefits such as minimal incisions, higher surgical restoration rate, low postoperative complications increase more patients opting for atherectomy devices.All the manufacturing firms should ensure that the products are safe and do not endanger the end consumer.Tornus catheter is also associated with longer procedural duration time with 144 minutes versus the atherectomy devices 115 minutes.
UGC
Tadalista 20 is a proven Erectile Dysfunction medication delivering best results by treating the condition of ED within a short period.Which helps relax the muscles in the arteries of the penis, allowing increased blood flow, which leads to an erection during psychological or physical s**ual stimulation.Other ED prescription Dosagevilitra 40 OnlineTadalista Tablets
More

Top